Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Ten-year recurrence rates in young women with breast cancer by locoregional treatment approach.

Beadle BM, Woodward WA, Tucker SL, Outlaw ED, Allen PK, Oh JL, Strom EA, Perkins GH, Tereffe W, Yu TK, Meric-Bernstam F, Litton JK, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):734-44. doi: 10.1016/j.ijrobp.2008.04.078. Epub 2008 Aug 15.

2.

Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.

Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.

Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1337-47.

PMID:
15817335
3.

Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?

Mamtani A, Patil S, Stempel MM, Morrow M.

Cancer. 2017 Jul 15;123(14):2626-2633. doi: 10.1002/cncr.30658. Epub 2017 Mar 23.

PMID:
28334423
4.

Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

Abdulkarim BS, Cuartero J, Hanson J, DeschĂȘnes J, Lesniak D, Sabri S.

J Clin Oncol. 2011 Jul 20;29(21):2852-8. doi: 10.1200/JCO.2010.33.4714. Epub 2011 Jun 13.

5.

Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.

Lupe K, Truong PT, Alexander C, Speers C, Tyldesley S.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e681-8. doi: 10.1016/j.ijrobp.2010.12.020. Epub 2011 Feb 6.

PMID:
21300456
6.

Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.

Levy A, Borget I, Bahri M, Arnedos M, Rivin E, Vielh P, Balleyguier C, Rimareix F, Bourgier C.

Breast J. 2014 Jul-Aug;20(4):381-7. doi: 10.1111/tbj.12277. Epub 2014 Jun 2.

PMID:
24890310
7.

Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.

Danforth DN Jr, Zujewski J, O'Shaughnessy J, Riseberg D, Steinberg SM, McAtee N, Noone M, Chow C, Chaudhry U, Lippman M, Jacobson J, Okunieff P, Cowan KH.

Ann Surg Oncol. 1998 Mar;5(2):150-8.

PMID:
9527268
8.

Predicting breast cancer recurrence following breast-conserving therapy: a single-institution analysis consisting of 764 Chinese breast cancer cases.

Li S, Yu KD, Fan L, Hou YF, Shao ZM.

Ann Surg Oncol. 2011 Sep;18(9):2492-9. doi: 10.1245/s10434-011-1626-2. Epub 2011 Mar 1.

PMID:
21360247
9.

The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.

Fowble B, Hanlon AL, Patchefsky A, Freedman G, Hoffman JP, Sigurdson ER, Goldstein LJ.

Int J Radiat Oncol Biol Phys. 1998 Aug 1;42(1):105-15.

PMID:
9747827
10.
11.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
13.

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation.

Woodward WA, Strom EA, Tucker SL, Katz A, McNeese MD, Perkins GH, Buzdar AU, Hortobagyi GN, Hunt KK, Sahin A, Meric F, Sneige N, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):336-44.

PMID:
12957243
14.

Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.

Kindts I, Buelens P, Laenen A, Van Limbergen E, Janssen H, Wildiers H, Weltens C.

Breast. 2017 Apr;32:18-25. doi: 10.1016/j.breast.2016.12.007. Epub 2016 Dec 22.

PMID:
28012411
15.

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.

Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA.

Int J Radiat Oncol Biol Phys. 2005 Jun 1;62(2):351-7.

PMID:
15890574
16.

Risk of local failure in breast cancer patients with lobular carcinoma in situ at the final surgical margins: is re-excision necessary?

Sadek BT, Shenouda MN, Abi Raad RF, Niemierko A, Keruakous AR, Goldberg SI, Taghian AG.

Int J Radiat Oncol Biol Phys. 2013 Nov 15;87(4):726-30. doi: 10.1016/j.ijrobp.2013.08.012. Epub 2013 Sep 21.

PMID:
24064317
17.

Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.

Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):357-64. doi: 10.1016/j.ijrobp.2008.04.034.

PMID:
18676091
18.

Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.

Patterson SG, Teller P, Iyengar R, Carlson GW, Gabram-Mendola SG, Losken A, Styblo T, Torres M, Wood WC, Perez SD, Mosunjac M, Rizzo M.

Ann Surg Oncol. 2012 Aug;19(8):2679-84. doi: 10.1245/s10434-012-2329-z. Epub 2012 Apr 3.

PMID:
22476750
19.

Long-term survival outcomes following internal mammary node irradiation in stage II-III breast cancer: results of a large retrospective study with 12-year follow-up.

Chang JS, Park W, Kim YB, Lee IJ, Keum KC, Lee CG, Choi DH, Suh CO, Huh SJ.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):867-72. doi: 10.1016/j.ijrobp.2013.02.037. Epub 2013 Jun 6.

PMID:
23747215
20.

Impact of primary local treatment on the development of distant metastases or death through locoregional recurrence in young breast cancer patients.

Bantema-Joppe EJ, van den Heuvel ER, de Munck L, de Bock GH, Smit WG, Timmer PR, Dolsma WV, Jansen L, Schröder CP, Siesling S, Langendijk JA, Maduro JH.

Breast Cancer Res Treat. 2013 Aug;140(3):577-85. doi: 10.1007/s10549-013-2650-7. Epub 2013 Aug 3.

PMID:
23912958

Supplemental Content

Support Center